Erectile Dysfunction, Premature Ejaculation
Conditions
Brief summary
The first large population-based study to evaluate erectile dysfunction (ED) and premature ejaculation (PE) in Poland. The study objective is to assess the prevalence and bother of ED and PE in the representative group of male population of Poland.
Interventions
DIAGNOSTIC_TESTQuestionnaires
Participants will be asked to complete validated questionnaires (the five-item International Index of Erectile Function - IIEF-5, Premature Ejaculation Diagnostic Tool - PEDT, International Prostate Symptom Score - IPSS, Overactive Bladder - Validated 8-question Screener - OAB-V8, Hospital Anxiety and Depression Scale - HADS, Athens Insomnia Scale - AIS).
Sponsors
Jagiellonian University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age ≥18 * A sufficient level of education to understand study procedures and be able to communicate with site personnel
Exclusion criteria
• Age \<18
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of ED in Poland | Through study completion, an average of 3 months | The prevalence of ED will be assessed using the five-item International Index of Erectile Function (IIEF-5; the lowest score 5; the highest score 25; the lower the score, the greater the severity of the symptoms) |
| Prevalence of PE in Poland | Through study completion, an average of 3 months | The prevalence of PE will be assessed using the Premature Ejaculation Diagnostic Tool (PEDT; the lowest score 0; the highest score 20; the lower the score, the lower the severity of the symptoms) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of overactive bladder in patients with PE and ED in Poland | Through study completion, an average of 3 months | The prevalence of overactive bladder will be assessed with the Overactive Bladder - Validated 8-question Screener (OAB-V8; the lowest score 0; the highest score 40; the lower the score, the lower the severity of the symptoms) |
| Bother of ED and PE in Poland | Through study completion, an average of 3 months | The degree of associated bother will be assessed using Likert scale (Likert scale: delighted \[score 0\], pleased \[score 1\], mostly satisfied \[score 2\], mixed \[score 3\], mostly dissatisfied \[score 4\], unhappy \[score 5\], or terrible \[score 6\]). |
| Prevalence of insomnia in patients with PE and ED in Poland | Through study completion, an average of 3 months | The prevalence of insomnia will be assessed with the Athens Insomnia Scale (AIS; the lowest score 0; the highest score 24; the lower the score, the lower the severity of the symptoms) |
| Prevalence of depressive symptoms in patients with PE and ED in Poland | Through study completion, an average of 3 months | The prevalence of depressive symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS; the lowest score 0; the highest score 48; the lower the score, the lower the severity of the symptoms) |
| Prevalence of lower urinary tract symptoms in patients with PE and ED in Poland | Through study completion, an average of 3 months | The prevalence of lower urinary tract symptoms will be assessed with the International Prostate Symptom Score (IPSS; the lowest score 0, the highest score 35, the lower the score, the lower the severity of the symptoms) |
Countries
Poland
Outcome results
None listed